Request for Covid-19 Impact Assessment of this Report
Scope of the Report:
This report focuses on the Antivenom in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
CSL Behring
Merck & Co., Inc.
BTG Plc
Pfizer
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
Market Segment by Countries, covering
United States
Canada
Mexico
Market Segment by Type, covers
Polyvalent antivenom
Monovalent antivenom
Market Segment by Applications, can be divided into
Retail Pharmacies
Hospitals
Others
There are 15 Chapters to deeply display the North America Antivenom market.
Chapter 1, to describe Antivenom Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Antivenom, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Antivenom, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Antivenom market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Antivenom Research Findings and Conclusion, Appendix, methodology and data source
1 Market Overview
1.1 Antivenom Introduction
1.2 Market Analysis by Type
1.2.1 Polyvalent antivenom
1.2.2 Monovalent antivenom
1.3 Market Analysis by Applications
1.3.1 Retail Pharmacies
1.3.2 Hospitals
1.3.3 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 Profile
2.1.2 Antivenom Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 CSL Behring News
2.2 Merck & Co., Inc.
2.2.1 Profile
2.2.2 Antivenom Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Merck & Co., Inc. News
2.3 BTG Plc
2.3.1 Profile
2.3.2 Antivenom Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 BTG Plc News
2.4 Pfizer
2.4.1 Profile
2.4.2 Antivenom Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Pfizer News
2.5 Haffkine Bio-Pharmaceutical Corporation
2.5.1 Profile
2.5.2 Antivenom Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Haffkine Bio-Pharmaceutical Corporation News
2.6 Rare Disease Therapeutics
2.6.1 Profile
2.6.2 Antivenom Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Rare Disease Therapeutics News
2.7 Flynn Pharma
2.7.1 Profile
2.7.2 Antivenom Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Flynn Pharma News
2.8 Vins Bioproducts
2.8.1 Profile
2.8.2 Antivenom Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Vins Bioproducts News
2.9 Bharat Serums and Vaccines
2.9.1 Profile
2.9.2 Antivenom Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Bharat Serums and Vaccines News
2.10 Serum Biotech
2.10.1 Profile
2.10.2 Antivenom Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 Serum Biotech News
3 North America Antivenom Market Competition, by Manufacturer
3.1 North America Antivenom Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Antivenom Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Antivenom Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Antivenom Manufacturer Market Share
3.4.2 Top 5 Antivenom Manufacturer Market Share
3.5 Market Competition Trend
4 North America Antivenom Market Analysis by Countries
4.1 North America Antivenom Sales Market Share by Countries
4.2 North America Antivenom Sales by Countries (2012-2017)
4.3 North America Antivenom Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Antivenom by Type
5.1 North America Antivenom Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Antivenom Sales and Market Share by Type (2012-2017)
5.1.2 North America Antivenom Revenue and Market Share by Type (2012-2017)
5.2 Polyvalent antivenom Sales Growth and Price
5.2.1 North America Polyvalent antivenom Sales Growth (2012-2017)
5.2.2 North America Polyvalent antivenom Price (2012-2017)
5.3 Monovalent antivenom Sales Growth and Price
5.3.1 North America Monovalent antivenom Sales Growth (2012-2017)
5.3.2 North America Monovalent antivenom Price (2012-2017)
6 North America Market Segmentation Antivenom by Application
6.1 North America Antivenom Sales Market Share by Application (2012-2017)
6.2 Retail Pharmacies Sales Growth (2012-2017)
6.3 Hospitals Sales Growth (2012-2017)
6.4 Others Sales Growth (2012-2017)
7 United States Antivenom Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Antivenom Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Antivenom Sales and Market Share by Type
7.3 United States Antivenom Sales by Application (2012-2017)
7.4 United States Antivenom Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Antivenom Sales and Market Share by Manufacturer
7.4.2 United States Antivenom Revenue and Market Share by Manufacturer
7.5 United States Antivenom Export and Import (2012-2017)
8 Canada Antivenom Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Antivenom Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Antivenom Sales and Market Share by Type
8.3 Canada Antivenom Sales by Application (2012-2017)
8.4 Canada Antivenom Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Antivenom Sales and Market Share by Manufacturer
8.4.2 Canada Antivenom Revenue and Market Share by Manufacturer
8.5 Canada Antivenom Export and Import (2012-2017)
9 Mexico Antivenom Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Antivenom Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Antivenom Sales and Market Share by Type
9.3 Mexico Antivenom Sales by Application (2012-2017)
9.4 Mexico Antivenom Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Antivenom Sales and Market Share by Manufacturer
9.4.2 Mexico Antivenom Revenue and Market Share by Manufacturer
9.5 Mexico Antivenom Export and Import (2012-2017)
10 Antivenom Market Forecast (2017-2022)
10.1 North America Antivenom Sales, Revenue and Growth Rate (2017-2022)
10.2 Antivenom Market Forecast by Countries (2017-2022)
10.2.1 United States Antivenom Forecast (2017-2022)
10.2.2 Canada Antivenom Forecast (2017-2022)
10.2.3 Mexico Antivenom Forecast (2017-2022)
10.3 Antivenom Market Forecast by Type (2017-2022)
10.4 Antivenom Market Forecast by Application (2017-2022)
11 Antivenom Manufacturing Cost Analysis
11.1 Antivenom Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Antivenom
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Antivenom Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Antivenom Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
Figure Antivenom Picture
Table Product Specifications of Antivenom
Figure North America Sales Market Share of Antivenom by Types in 2016
Table Types of Antivenom
Figure Polyvalent antivenom Picture
Table Major Manufacturers of Polyvalent antivenom
Figure Monovalent antivenom Picture
Table Major Manufacturers of Monovalent antivenom
Table North America Antivenom Sales Market Share by Applications in 2016
Table Applications of Antivenom
Figure Retail Pharmacies Picture
Figure Hospitals Picture
Figure Others Picture
Figure United States Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Antivenom Revenue (Million USD) and Growth Rate (2012-2022)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Antivenom Type and Applications
Table CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Antivenom Type and Applications
Table Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BTG Plc Basic Information, Manufacturing Base and Competitors
Table BTG Plc Antivenom Type and Applications
Table BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antivenom Type and Applications
Table Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Type and Applications
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table Rare Disease Therapeutics Antivenom Type and Applications
Table Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table Flynn Pharma Antivenom Type and Applications
Table Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table Vins Bioproducts Antivenom Type and Applications
Table Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table Bharat Serums and Vaccines Antivenom Type and Applications
Table Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Biotech Basic Information, Manufacturing Base and Competitors
Table Serum Biotech Antivenom Type and Applications
Table Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Antivenom Sales by Manufacturer (2016-2017)
Figure North America Antivenom Sales Market Share by Manufacturer in 2016
Figure North America Antivenom Sales Market Share by Manufacturer in 2017
Table North America Antivenom Revenue by Manufacturer (2016-2017)
Figure North America Antivenom Revenue Market Share by Manufacturer in 2016
Figure North America Antivenom Revenue Market Share by Manufacturer in 2017
Table North America Antivenom Price by Manufacturers (2016-2017)
Figure Top 3 Antivenom Manufacturer Market Share in 2016
Figure Top 3 Antivenom Manufacturer Market Share in 2017
Figure Top 5 Antivenom Manufacturer Market Share in 2016
Figure Top 5 Antivenom Manufacturer Market Share in 2017
Figure North America Antivenom Sales and Growth (2012-2017)
Table North America Antivenom Sales by Countries (2012-2017)
Table North America Antivenom Sales Market Share by Countries (2012-2017)
Figure North America 2012 Antivenom Sales Market Share by Countries
Figure North America 2016 Antivenom Sales Market Share by Countries
Figure North America Antivenom Revenue and Growth (2012-2017)
Table North America Antivenom Revenue by Countries (2012-2017)
Table North America Antivenom Revenue Market Share by Countries (2012-2017)
Table North America 2012 Antivenom Revenue Market Share by Countries
Table North America 2016 Antivenom Revenue Market Share by Countries
Table North America Antivenom Sales by Type (2012-2017)
Table North America Antivenom Sales Share by Type (2012-2017)
Table North America Antivenom Revenue by Type (2012-2017)
Table North America Antivenom Revenue Share by Type (2012-2017)
Figure North America Polyvalent antivenom Sales Growth (2012-2017)
Figure North America Polyvalent antivenom Price (2012-2017)
Figure North America Monovalent antivenom Sales Growth (2012-2017)
Figure North America Monovalent antivenom Price (2012-2017)
Table North America Antivenom Sales by Application (2012-2017)
Table North America Antivenom Sales Share by Application (2012-2017)
Figure North America Retail Pharmacies Sales Growth (2012-2017)
Figure North America Hospitals Sales Growth (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure United States Antivenom Revenue and Growth (2012-2017)
Figure United States Antivenom Sales and Growth (2012-2017)
Table United States Antivenom Sales by Type (2012-2017)
Table United States Antivenom Sales Market Share by Type (2012-2017)
Table United States Antivenom Sales by Application (2012-2017)
Table United States Antivenom Sales Market Share by Application (2012-2017)
Table United States Antivenom Sales by Manufacturer (2016-2017)
Figure United States Antivenom Sales Market Share by Manufacturer in 2016
Figure United States Antivenom Sales Market Share by Manufacturer in 2017
Table United States Antivenom Revenue by Manufacturer (2016-2017)
Figure United States Antivenom Revenue Market Share by Manufacturer in 2016
Figure United States Antivenom Revenue Market Share by Manufacturer in 2017
Table United States Antivenom Export and Import (2012-2017)
Figure Canada Antivenom Revenue and Growth (2012-2017)
Figure Canada Antivenom Sales and Growth (2012-2017)
Table Canada Antivenom Sales by Type (2012-2017)
Table Canada Antivenom Sales Market Share by Type (2012-2017)
Table Canada Antivenom Sales by Application (2012-2017)
Table Canada Antivenom Sales Market Share by Application (2012-2017)
Table Canada Antivenom Sales by Manufacturer (2016-2017)
Figure Canada Antivenom Sales Market Share by Manufacturer in 2016
Figure Canada Antivenom Sales Market Share by Manufacturer in 2017
Table Canada Antivenom Revenue by Manufacturer (2016-2017)
Figure Canada Antivenom Revenue Market Share by Manufacturer in 2016
Figure Canada Antivenom Revenue Market Share by Manufacturer in 2017
Table Canada Antivenom Export and Import (2012-2017)
Figure Mexico Antivenom Revenue and Growth (2012-2017)
Figure Mexico Antivenom Sales and Growth (2012-2017)
Table Mexico Antivenom Sales by Type (2012-2017)
Table Mexico Antivenom Sales Market Share by Type (2012-2017)
Table Mexico Antivenom Sales by Application (2012-2017)
Table Mexico Antivenom Sales Market Share by Application (2012-2017)
Table Mexico Antivenom Sales by Manufacturer (2016-2017)
Figure Mexico Antivenom Sales Market Share by Manufacturer in 2016
Figure Mexico Antivenom Sales Market Share by Manufacturer in 2017
Table Mexico Antivenom Revenue by Manufacturer (2016-2017)
Figure Mexico Antivenom Revenue Market Share by Manufacturer in 2016
Figure Mexico Antivenom Revenue Market Share by Manufacturer in 2017
Table Mexico Antivenom Export and Import (2012-2017)
Figure North America Antivenom Sales, Revenue and Growth Rate (2017-2022)
Table North America Antivenom Sales Forecast by Countries (2017-2022)
Table North America Antivenom Market Share Forecast by Countries (2017-2022)
Figure United States Antivenom Sales Forecast (2017-2022)
Figure Canada Antivenom Sales Forecast (2017-2022)
Figure Mexico Antivenom Sales Forecast (2017-2022)
Table North America Antivenom Sales Forecast by Type (2017-2022)
Table North America Antivenom Market Share Forecast by Type (2017-2022)
Table North America Antivenom Sales Forecast by Application (2017-2022)
Table North America Antivenom Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antivenom
Figure Manufacturing Process Analysis of Antivenom
Figure Antivenom Industrial Chain Analysis
Table Raw Materials Sources of Antivenom Major Manufacturers in 2016
Table Major Buyers of Antivenom
Table Distributors/Traders/ Dealers List
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...